Related content

Reoperative Heller Myotomy: More Pain, Less Gain

By Wood Thomas W.   Ross Sharona B.   Ryan Carrie E.   Bowman Ty A.   Jacobi Benjamin L.   Konstantinidis Michael G.   Rosemurgy Alexander S.  

The American Surgeon, Vol. 81, Iss. 6, 2015-06 ,pp. : 637-645

Southeastern Surgical Congress

Access to resources Recommend Favorite

Report of a unique meeting between the alpha-blocker subcommittee and the pharmaceutical industry

By McGrath J.C.   Lepor H.   Wyllie M.G.  

Urology, Vol. 48, Iss. 5, 1996-11 ,pp. : 665-667

Elsevier

Access to resources Recommend Favorite

Risk/Benefit Evaluation of Drugs: The Role of the Pharmaceutical Industry in Germany

By  

European Surgical Research, Vol. 34, Iss. 1-2, 2002-03 ,pp. : 203-207

Karger

Access to resources Recommend Favorite

Lessons from the past: directions for the future: Do new marketed surgical procedures and grafts produce ethical, personal liability, and legal concerns for physicians?

By Ostergard Donald  

International Urogynecology Journal, Vol. 18, Iss. 6, 2007-06 ,pp. : 591-598

Springer Publishing Company

Access to resources Recommend Favorite

Use of a patient information leaflet to influence patient decisions regarding mode of administration of NSAID medications in case of acute low back pain

By Rosemann Thomas   Joos Stefanie   Koerner Thorsten   Heiderhoff Marc   Laux Gunter   Szecsenyi Joachim  

European Spine Journal, Vol. 15, Iss. 11, 2006-11 ,pp. : 1737-1741

Springer Publishing Company

Access to resources Recommend Favorite